InvestorsHub Logo
Followers 53
Posts 1776
Boards Moderated 0
Alias Born 03/22/2015

Re: elichen post# 339501

Thursday, 07/23/2020 10:02:50 PM

Thursday, July 23, 2020 10:02:50 PM

Post# of 401702

i wonder how much $$$ the drugs thatNas sold for pennies have generated for the company that got them so cheap?!?!





I don't think they've had them long enough to commercialize yet, especially since they didn't do any of the bioequivalence tests or other proofing studies. We did all that, the shareholders, through dilution. But if you like the feeling of a gut-punch, feel free to look up our Norco and Percocet ANDA's in the FDA Orange Book, now listed under Nostrum ownership.


What would Percocet and Norco have done last year? 100% Elite owned. $20M? $30M? $50M?

What was the R&D for Percocet, Norco, methadone, Tylenol #3? (All filed in 2016 or after.) $10M? 20M? How many shares was that? 150M? 250M?


Percocet... approved 7/18... $500M... 16 competitors
Norco... approved 11/18... $447M... 11 competitors
Tyl w codeine...approved 9/19... $45M... 8 competitors
Methadone... approved 8/18... $30M... 10 competitors
hydromorphone... approved 1/12... $30M... 8 competitors


And, again, if anyone can make me understand why we bashed in the skulls of our geese that lay the golden eggs, I still don't get it. Expensive friggin geese.






Occam's razor: the simplest solution is most likely the right one.

Hanlon's razor: never attribute to malice that which is adequately explained by stupidity.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News